Unresectable hepatocellular carcinoma (HCC) is rarely an isolated oncologic condition. In patients with cirrhosis, tumor control and hepatic reserve are inextricably intertwined, with portal hypertension (PH) potentially shaping both the safe delivery of systemic therapy and the magnitude of its clinical benefit.
Beyond replacing endoscopy: portal hypertension assessment by AI in unresectable HCC
Vozza, Alfredo;
2026-01-01
Abstract
Unresectable hepatocellular carcinoma (HCC) is rarely an isolated oncologic condition. In patients with cirrhosis, tumor control and hepatic reserve are inextricably intertwined, with portal hypertension (PH) potentially shaping both the safe delivery of systemic therapy and the magnitude of its clinical benefit.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
